CDKN2A and neoplasm: Supervised and unsupervised clustering analysis of the samples showed no correlations between phosphorylation patterns of kinase substrates and known molecular (BRAF-, NRAS-, CDKN2A-, or TP53 mutational status) or clinical parameters (age, gender, stage, or anatomical location of tumor), including response to DTIC (Figure 1B).